Clinical Trials Logo

Clinical Trial Summary

AOC 1001-CS1 is a randomized, double-blind, placebo-controlled, Phase 1/2 study to evaluate the safety, tolerability, pharmacokinetics and pharmacodynamics of single and multiple-doses of AOC 1001 Administered Intravenously to Adult Myotonic Dystrophy Type 1 (DM1) patients (MARINA). Part A is a single dose design with 1 cohort (dose level). In Part A, the patient duration is 6 months as the treatment period is 1 day followed by a 6 month follow-up period. Part B is a multiple-ascending dose design with 3 cohorts (dose levels). In Part B, the patient duration is 6 months as the treatment period is 3 months followed by a 3 month follow-up period.


Clinical Trial Description

n/a


Study Design


Related Conditions & MeSH terms


NCT number NCT05027269
Study type Interventional
Source Avidity Biosciences, Inc.
Contact Avidity Biosciences, Inc.
Phone 858-771-7038
Email [email protected]
Status Not yet recruiting
Phase Phase 1/Phase 2
Start date October 2021
Completion date September 2023

See also
  Status Clinical Trial Phase
Recruiting NCT02880735 - Ventilatory Response After Non Invasive Ventilation in Type 1 Myotonic Dystrophy N/A
Active, not recruiting NCT04698551 - NIPD on cffDNA for Triplet Repeat Diseases
Recruiting NCT04712422 - Poor Neck Proprioception May Cause Balance Deficits in Myotonic Dystrophy 1
Recruiting NCT05006924 - Symptoms and Outcome Measures for Upper- Limb Function in Myotonic Dystrophy Type 1
Recruiting NCT04634682 - Effect of MYODM on Quality of Life, Fatigue and Hypersomnia in Patients With Myotonic Dystrophy Type 1 N/A
Completed NCT02729597 - Tracking the Brain in Myotonic Dystrophies: a 5-year Longitudinal Follow-up Study N/A
Recruiting NCT04886518 - Safety and Efficacy of Pitolisant on Excessive Daytime Sleepiness and Other Non-Muscular Symptoms in Patients With Myotonic Dystrophy Type 1 Phase 2
Recruiting NCT05036447 - Myotonic Dystrophy Type 1 and Resistance Exercise N/A
Recruiting NCT03424460 - Venous Thromboembolism in Myotonic Dystrophy Type 1 N/A
Completed NCT04001920 - Effects of a Multiple Component Training Program on Muscles in Adults With Myotonic Dystrophy Type 1 N/A
Completed NCT02858908 - Study of Tideglusib in Adolescent and Adult Patients With Myotonic Dystrophy Phase 2
Completed NCT04018820 - Effects of a 12-week Strength Training Program in Men With Myotonic Dystrophy Type 1 N/A
Not yet recruiting NCT04656210 - Myotonic Dystrophy - Vascular and Cognition
Completed NCT03141749 - Venous Thromboembolism in DM1 N/A
Recruiting NCT03981575 - Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type 1 (END-DM1)
Recruiting NCT02398786 - Myotonic Dystrophy Family Registry
Recruiting NCT03784586 - Sudden Cardiac Death Stratification in Myotonic Dystrophy Type 1 Patients
Active, not recruiting NCT04187482 - Myotonic Dystrophy Type 1 Aerobic Exercise Study N/A
Completed NCT02251457 - Study of Ranolazine in Myotonia Congenita, Paramyotonia Congenita and Myotonic Dystrophy Type 1 Phase 1
Enrolling by invitation NCT04052958 - DM-IMT - Controlled, Randomized, Three-arm Intervention Study on the Safety and Efficacy of Regular Respiratory Muscle Training in Patients With Myotonic Dystrophy Type 1 N/A